CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (2,885)	$ (7,737)
Adjustments to reconcile net income or loss to net cash from operating activities:
Depreciation and amortization	40,879	39,897
Allowance for credit losses	4,665	4,308
Stock-based compensation	2,390	3,245
Amortization of debt fees	3,068	2,118
Gain on debt redemption	0	(2,836)
Restructuring charges	4,315	3,599
Restructuring payments	(14,989)	(4,641)
Pension contributions and retiree medical payments	(11,767)	(19,938)
Other, net	(1,548)	4,172
Changes in operating assets and liabilities, net of acquisitions/divestitures:
Accounts and other receivables	30,053	69,841
Finance receivables	27,716	15,596
Inventories	(9,005)	(10,226)
Other current assets and prepayments	(19,471)	(8,380)
Accounts payable and accrued liabilities	(83,398)	(103,990)
Current and noncurrent income taxes	16,897	(6,070)
Advance billings	555	(18,672)
Net cash from operating activities	(12,525)	(39,714)
Cash flows from investing activities:
Capital expenditures	(19,957)	(28,666)
Purchases of investment securities	(14,197)	(5,180)
Proceeds from sales/maturities of investment securities	23,624	5,976
Net investment in loan receivables	(2,115)	(12,879)
Other investing activities, net	804	(664)
Net cash from investing activities	(11,841)	(41,413)
Cash flows from financing activities:
Principal payments of debt	(14,132)	(31,018)
Dividends paid to stockholders	(8,832)	(8,725)
Customer deposits at Pitney Bowes Bank	(29,347)	(33,526)
Other financing activities, net	(6,122)	(6,173)
Net cash from financing activities	(58,433)	(79,442)
Effect of exchange rate changes on cash and cash equivalents	(2,162)	2,349
Change in cash and cash equivalents	(84,961)	(158,220)
Cash and cash equivalents at beginning of period	601,053	669,981
Cash and cash equivalents at end of period	$ 516,092	$ 511,761